Given that the expression and intercellular crosstalk of LOX, LOXL2, and LOXL4 play critical roles in TME formation and the progression of HCC, elucidation of their regulatory pathways may identify promising therapeutic targets. This evidence concerns the gene LOXL4 and hepatocellular carcinoma.